TABLE 1.

Summary of chemotherapy, ICIs, and targeted therapy drug names.

Categories	Drug names
Chemotherapy	Platinum drugs: Cisplatin; Carboplatin; Paraplatin; Nedaplatin; Oxaliplatin
	Pemetrexed: Pemetrexed; Alimta
	Gemcitabine: Gemcitabine; Gemzar
	Taxoid drugs: Paclitaxel; Taxol; Albumin-bound paclitaxel; Nab-paclitaxel; Abraxane; Docetaxel; Taxotere; Anzatax
	Vindesine: Vindesine; Vinorelbine; Navelbine
	Etoposide: Etoposide; VP-16
	Other drugs: Irinotecan; Topotecan; Mitomycin; Amrubicin; Ifosfamide; Cyclophosphamide; Bortezomib; Everolimus; Temozolomide; Thalomid; Capecitabine; Fluorouracil; 5-FU
ICIs	Anti-PD-1 inhibitors: Nivolumab; Pembrolizumab; Cemiplimab; Opdivo; Keytruda; Libtayo
	Anti-PD-L1 inhibitors: Atezolizumab; Durvalumab; Avelumab; Imfinzi; Bavencio; Tecentriq
	Anti-CTLA4 inhibitors: Ipilimumab; Tremelimumab; Yervoy
Targeted therapy	EGFR-TKI: Iressa; Gefitinib; Tarceva; Erlotinib; Gilotrif; Afatinib; Tagrisso; Osimertinib; Dacomitinib; Vizimpro; Lapatinib; Tykerb; Icotinib; Conmana
	EGFR antibody: Cetuximab; Erbitux
	ALK-TKI: Crizotinib; Xalkori; Alectinib; Alecensa; Ceritinib; Zykadia; Entrectinib; Rozlytrek; Brigatinib; Alunbrig; Lorlatinib; Lorviqua
	Other drugs: Cediranib; Temsirolimus (CCI-779); Endostatin; Sorafenib; Herceptin; Trastuzumab; Rituxan; Rituximab; Trebananib (AMG 386); Endostatin; Faslodex; Lucentis